Home LiteratureArticle Details
PMID: 20683944 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.

Hepatology (Baltimore, Md.) ·Vol. 52 ·No. 2 ·2010-08-00 ·Pages 443-53

Woodhouse SD, Narayan R, Latham S, Lee S, Antrobus R, Gangadharan B, Luo S, Schroth GP, Klenerman P, Zitzmann N

Abstract

Hepatitis C virus (HCV) is a major cause of liver disease but the full impact of HCV infection on the hepatocyte is poorly understood. RNA sequencing (RNA-Seq) is a novel method to analyze the full transcriptional activity of a cell or tissue, thus allowing new insight into the impact of HCV infection. We conducted the first full-genome RNA-Seq analysis in a host cell to analyze infected and noninfected cells, and compared this to microarray and proteomic analyses. The combined power of the triple approach revealed that HCV infection affects a number of previously unreported canonical pathways and biological functions, including pregnane X receptor/retinoic acid receptor activation as a potential host antiviral response, and integrin-linked kinase signaling as an entry factor. This approach also identified several mechanisms implicated in HCV pathogenesis, including an increase in reactive oxygen species. HCV infection had a broad effect on cellular metabolism, leading to increases in cellular cholesterol and free fatty acid levels, associated with a profound and specific decrease in cellular glucose levels. RNA-Seq technology, especially when combined with established methods, demonstrated that HCV infection has potentially wide-ranging effects on cellular gene and protein expression. This in vitro study indicates a substantial metabolic impact of HCV infection and highlights new mechanisms of virus-host interaction which may be highly relevant to pathogenesis in vivo.

MeSH Terms
Cells, Cultured Gene Expression Profiling Hepatitis C/genetics,metabolism Microarray Analysis Proteome
Chemicals
Proteome
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Woodhouse Stephen D
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK. Stephen.woodhouse@bioch.ox.ac.uk
Narayan Ramamurthy
Latham Sally
Lee Sheena
Antrobus Robin
Gangadharan Bevin
Luo Shujun
Schroth Gary P
Klenerman Paul
Zitzmann Nicole
References (48)
48 references, click to expand
  1. Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.
    J Gastroenterol. 2009;44 Suppl 19:82-8 PMID: 19148799
  2. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury.
    Hepatology. 2008 Nov;48(5):1430-9 PMID: 18972446
  3. A peptide from autoantigen La blocks poliovirus and hepatitis C virus cap-independent translation and reveals a single tyrosine critical for La RNA binding and translation stimulation.
    J Virol. 2004 Apr;78(7):3763-76 PMID: 15016896
  4. RNA-seq: from technology to biology.
    Cell Mol Life Sci. 2010 Feb;67(4):569-79 PMID: 19859660
  5. Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication.
    Virology. 2005 Apr 25;335(1):72-86 PMID: 15823607
  6. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
    Hepatology. 2006 Jul;44(1):117-25 PMID: 16799963
  7. Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes.
    PLoS Pathog. 2009 Jan;5(1):e1000269 PMID: 19148281
  8. Hepatitis C virus hijacks host lipid metabolism.
    Trends Endocrinol Metab. 2010 Jan;21(1):33-40 PMID: 19854061
  9. Cleavage of La protein by granzyme H induces cytoplasmic translocation and interferes with La-mediated HCV-IRES translational activity.
    Cell Death Differ. 2009 Feb;16(2):340-8 PMID: 19039329
  10. Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase.
    Hepatology. 2009 Sep;50(3):678-88 PMID: 19492433
  11. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication.
    Proc Natl Acad Sci U S A. 2009 May 5;106(18):7577-82 PMID: 19376974
  12. Novel role for integrin-linked kinase in modulation of coxsackievirus B3 replication and virus-induced cardiomyocyte injury.
    Circ Res. 2006 Aug 18;99(4):354-61 PMID: 16840719
  13. Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection.
    J Proteome Res. 2009 Jan;8(1):118-22 PMID: 19053806
  14. Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes.
    J Hepatol. 2009 May;50(5):872-82 PMID: 19303156
  15. Gonadotropin-induced delta14-reductase and delta7-reductase gene expression in cumulus cells during meiotic resumption of porcine oocytes.
    Endocrinology. 2005 Jan;146(1):186-94 PMID: 15459117
  16. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis.
    Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1661-6 PMID: 17234812
  17. Integrin-linked kinase plays a key role in coxsackievirus replication.
    Circ Res. 2006 Aug 18;99(4):346-7 PMID: 16917101
  18. TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis.
    Am J Physiol. 1999 Apr;276(4):G1059-68 PMID: 10198351
  19. Solexa Ltd.
    Pharmacogenomics. 2004 Jun;5(4):433-8 PMID: 15165179
  20. Polarity complex proteins.
    Biochim Biophys Acta. 2008 Mar;1778(3):614-30 PMID: 18005931
  21. Relationship between oxidative stress and hepatic glutathione levels in ethanol-mediated apoptosis of polarized hepatic cells.
    World J Gastroenterol. 2009 Jun 7;15(21):2609-16 PMID: 19496190
  22. Metallothionein protection against alcoholic liver injury through inhibition of oxidative stress.
    Exp Biol Med (Maywood). 2002 Mar;227(3):214-22 PMID: 11856821
  23. Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways.
    Hepatology. 2009 May;49(5):1469-82 PMID: 19235829
  24. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.
    Science. 1999 Jul 2;285(5424):110-3 PMID: 10390360
  25. Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260.
    J Biol Chem. 2006 Jun 2;281(22):15434-40 PMID: 16551633
  26. Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K.
    J Biol Chem. 1998 Jul 10;273(28):17651-9 PMID: 9651361
  27. Natural history of hepatitis C.
    Clin Liver Dis. 2005 Aug;9(3):383-98, vi PMID: 16023972
  28. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.
    Cell. 2006 Jan 13;124(1):119-31 PMID: 16413486
  29. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    J Hepatol. 2009 May;50(5):883-94 PMID: 19303158
  30. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays.
    Genome Res. 2008 Sep;18(9):1509-17 PMID: 18550803
  31. The transcriptional landscape of the yeast genome defined by RNA sequencing.
    Science. 2008 Jun 6;320(5881):1344-9 PMID: 18451266
  32. RNA-Seq: a revolutionary tool for transcriptomics.
    Nat Rev Genet. 2009 Jan;10(1):57-63 PMID: 19015660
  33. Complete replication of hepatitis C virus in cell culture.
    Science. 2005 Jul 22;309(5734):623-6 PMID: 15947137
  34. Glucocorticosteroids increase cell entry by hepatitis C virus.
    Gastroenterology. 2010 May;138(5):1875-84 PMID: 20152835
  35. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.
    Nature. 2007 Apr 12;446(7137):801-5 PMID: 17325668
  36. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus.
    J Virol. 2008 Apr;82(7):3555-60 PMID: 18234789
  37. Estimating accuracy of RNA-Seq and microarrays with proteomics.
    BMC Genomics. 2009 Apr 16;10:161 PMID: 19371429
  38. Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling.
    EMBO J. 2006 Nov 1;25(21):5058-70 PMID: 17053785
  39. Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites.
    Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2198-203 PMID: 15671183
  40. Mapping and quantifying mammalian transcriptomes by RNA-Seq.
    Nat Methods. 2008 Jul;5(7):621-8 PMID: 18516045
  41. The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation.
    Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2249-54 PMID: 9122180
  42. Hepatitis C virus and type 2 diabetes.
    World J Gastroenterol. 2009 Apr 7;15(13):1537-47 PMID: 19340895
  43. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.
    Nat Med. 2005 Jul;11(7):791-6 PMID: 15951748
  44. Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development.
    Hepatology. 2009 Jul;50(1):6-16 PMID: 19437494
  45. Robust hepatitis C virus infection in vitro.
    Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9 PMID: 15939869
  46. Regulation of hepatic GLUT8 expression in normal and diabetic models.
    Endocrinology. 2003 May;144(5):1703-11 PMID: 12697674
  47. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus.
    Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G847-51 PMID: 16603728
  48. Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients.
    J Virol. 2005 Jun;79(12):7558-69 PMID: 15919910
Article Info
Journal
Hepatology (Baltimore, Md.)
Abbr.
Hepatology
ISSN
1527-3350
Published
2010-08-00
Pages
443-53
Language
English
Region
United States
NLM ID
8302946
PMCID
PMC3427885
Subset
IM
Grants
Wellcome Trust · 084655 · United Kingdom
PHS HHS · 1V19A1082630-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com